#759 — The Industry Wire

November 25, 2025 Brian Casey 0 min read
  1. GOP revolt derails White House launch of Obamacare subsidies.
  2. New federal loan limits could hinder medical training.
  3. Disappointing data for oral semaglutide for Alzheimer’s. 
  4. J&J Alzheimer’s drug also falls short in clinical trial.
  5. Hospital closures rock rural healthcare. 
  6. How the MAHA coalition drives public health policy.
  7. 2026 CMS rates may exacerbate hospitals’ financial woes. 
  8. Federal oversight stalls on e-bikes for kids.
  9. Investigators look for cause of contaminated infant formula.
  10. Mayo Clinic doubles Q3 operating income. 
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Artificial Intelligence December 11, 2025

FDA AI Approvals Surge Past 1k for Radiology December 11, 2025

The number of AI-enabled medical devices granted FDA marketing authorization for radiology surged past the 1k mark in the latest update from the agency. The numbers show that radiology’s share of authorizations remains stable at just over three-quarters of total approvals. The FDA regularly releases the list in what’s become a closely watched barometer of […]

Medical Imaging December 9, 2025

RSNA 2025 Video Highlights December 9, 2025

RSNA 2025 is a wrap, and this year’s meeting offers an intriguing look at the forces that are shaping radiology – especially AI and imaging informatics. It’s no secret that AI has come to dominate recent RSNA conferences, with its promise of fundamentally reshaping how radiologists do their jobs. But that dream has been a […]

Contrast December 8, 2025

Risks of Rising Contrast Use December 8, 2025

The use of contrast media in medical imaging procedures has been rising steadily in recent years, a trend that creates environmental risks. So says a new study in JAMA Network Open that documents growth in contrast use over the past 13 years.  Contrast is an essential part of many imaging exams, helping radiologists better visualize […]